- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Big Green Snowflakes
Swedish Pharmaceuticals & Biotech Big Green Snowflakes
Results
100
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
100 companies
BioGaia
Market Cap: SEK 10.2b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 100.80
7D
-1.7%
1Y
-2.3%
Camurus
Market Cap: SEK 36.7b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 615.00
7D
0.7%
1Y
12.9%
Bonesupport Holding
Market Cap: SEK 13.1b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 199.10
7D
-4.1%
1Y
-40.6%
Guard Therapeutics International
Market Cap: SEK 26.1m
A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.
GUARD
SEK 1.30
7D
-7.5%
1Y
-93.5%
Swedish Orphan Biovitrum
Market Cap: SEK 114.4b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 332.00
7D
-1.3%
1Y
9.9%
Biovica International
Market Cap: SEK 150.3m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.
BIOVIC B
SEK 0.55
7D
-7.1%
1Y
-68.3%
Saniona
Market Cap: SEK 2.2b
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.
SANION
SEK 16.28
7D
0.5%
1Y
471.2%
Ascelia Pharma
Market Cap: SEK 356.4m
A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
ACE
SEK 2.81
7D
-6.0%
1Y
3.3%
Vitrolife
Market Cap: SEK 18.9b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 139.50
7D
-2.1%
1Y
-36.3%
Xbrane Biopharma
Market Cap: SEK 205.1m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 9.96
7D
1.3%
1Y
-62.9%
IDL Diagnostics
Market Cap: SEK 97.7m
A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
IDLDX
SEK 0.42
7D
6.0%
1Y
1.4%
Devyser Diagnostics
Market Cap: SEK 1.8b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 109.00
7D
-4.4%
1Y
-17.4%
Elicera Therapeutics
Market Cap: SEK 263.1m
A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.
ELIC
SEK 5.42
7D
-0.6%
1Y
193.8%
Active Biotech
Market Cap: SEK 94.7m
A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.
ACTI
SEK 0.077
7D
-2.5%
1Y
-74.3%
AlzeCure Pharma
Market Cap: SEK 236.7m
Operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.
ALZCUR
SEK 2.06
7D
3.5%
1Y
80.7%
Moberg Pharma
Market Cap: SEK 408.4m
A pharmaceutical company, develops and commercializes medical products primarily in Sweden.
MOB
SEK 8.69
7D
-15.5%
1Y
-51.2%
Xspray Pharma
Market Cap: SEK 1.0b
A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.
XSPRAY
SEK 25.10
7D
-1.8%
1Y
-39.2%
Lipigon Pharmaceuticals
Market Cap: SEK 57.4m
Develops drugs for lipid related diseases in Sweden.
LPGO
SEK 0.095
7D
-5.2%
1Y
-30.9%
Abera Bioscience
Market Cap: SEK 116.2m
A platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally.
ABERA
SEK 6.30
7D
5.0%
1Y
63.2%
Egetis Therapeutics
Market Cap: SEK 2.2b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 5.56
7D
-10.0%
1Y
4.1%
BioArctic
Market Cap: SEK 24.8b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 280.20
7D
5.8%
1Y
55.9%
Mendus
Market Cap: SEK 281.1m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 5.54
7D
-4.6%
1Y
-40.1%
IRLAB Therapeutics
Market Cap: SEK 194.5m
IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other CNS disorders.
IRLAB A
SEK 2.29
7D
-1.3%
1Y
-82.2%
MedCap
Market Cap: SEK 8.0b
A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.
MCAP
SEK 531.00
7D
-2.9%
1Y
1.1%
Sprint Bioscience
Market Cap: SEK 70.5m
A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.
SPRINT
SEK 0.67
7D
2.8%
1Y
-55.1%
Annexin Pharmaceuticals
Market Cap: SEK 177.9m
A biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.
ANNX
SEK 25.20
7D
-6.0%
1Y
-45.2%
Spermosens
Market Cap: SEK 19.7m
Provides diagnostic health care products and services in Sweden.
SPERM
SEK 0.0062
7D
3.3%
1Y
-46.6%
Klaria Pharma Holding AB (publ.)
Market Cap: SEK 125.0m
A pharmaceutical company develops and commercializes medication for migraine and cancer related pain, and opioid overdose and anaphylactic shock.
KLAR
SEK 0.51
7D
6.3%
1Y
10.4%
Genovis AB (publ.)
Market Cap: SEK 1.3b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 20.00
7D
-2.4%
1Y
-27.7%
Spago Nanomedical
Market Cap: SEK 38.5m
A clinical phase nanomedicine company, engages in the development of nanomedicines for cancer diagnostics and treatment primarily in Sweden.
SPAGO
SEK 0.11
7D
2.8%
1Y
-41.2%
AcouSort
Market Cap: SEK 56.1m
A technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets.
ACOU
SEK 2.65
7D
6.0%
1Y
-77.7%
Corline Biomedical
Market Cap: SEK 439.6m
Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.
CLBIO
SEK 17.95
7D
-6.0%
1Y
173.6%
SynAct Pharma
Market Cap: SEK 1.1b
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 20.40
7D
-4.4%
1Y
150.3%
Oncopeptides
Market Cap: SEK 1.4b
A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.
ONCO
SEK 5.10
7D
4.4%
1Y
254.7%
Cinclus Pharma Holding
Market Cap: SEK 802.3m
A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.
CINPHA
SEK 17.24
7D
-5.4%
1Y
-11.0%
Biosergen
Market Cap: SEK 111.5m
A biotech company, develops antifungal products.
BIOSGN
SEK 0.47
7D
-0.2%
1Y
-27.1%